Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways

Background. Dihydroartemisinin (DHA) is a predominant compound in Artemisia annua L., and it has been shown to inhibit tumorigenesis. Methods. In this study, the antitumor potential of DHA was investigated in the MHCC97-L hepatocellular carcinoma cell line. Cells were treated at various concentratio...

Full description

Bibliographic Details
Main Authors: Long Wu, Yanlei Cheng, Junjian Deng, Weiping Tao, Junjie Ye
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2019/9581327
id doaj-f426284b3beb42538ec42d86469f4ccb
record_format Article
spelling doaj-f426284b3beb42538ec42d86469f4ccb2020-11-25T00:44:05ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882019-01-01201910.1155/2019/95813279581327Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB PathwaysLong Wu0Yanlei Cheng1Junjian Deng2Weiping Tao3Junjie Ye4Departments of Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, ChinaDepartments of Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, ChinaDepartments of Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, ChinaDepartments of Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, ChinaDepartments of Cancer Center, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, ChinaBackground. Dihydroartemisinin (DHA) is a predominant compound in Artemisia annua L., and it has been shown to inhibit tumorigenesis. Methods. In this study, the antitumor potential of DHA was investigated in the MHCC97-L hepatocellular carcinoma cell line. Cells were treated at various concentrations of DHA, and then the cell cycle, viability, and DNA synthesis were measured to evaluate cell proliferation. Furthermore, the expression of genes and proteins related to proliferation and apoptosis was measured to determine the effects of DHA. Finally, the mechanism was investigated using RNA-sequencing to identify differentially expressed genes and signaling pathways, and JNK/NF-κB pathways were evaluated with Western blotting. Results. Cells were treated with a concentration range of DHA from 1 to 100 μM, and cell proliferation was suppressed in a dose-dependent manner. In addition, the genes and proteins involved in typical cellular functions of MHCC97-L cells were significantly inhibited. DHA treatment downregulated the angiogenic gene ANGPTL2 and the cell proliferation genes CCND1, E2F1, PCNA, and BCL2. DHA treatment significantly upregulated the apoptotic genes CASP3, CASP8, CASP9, and TNF. Global gene expression profiles identified 2064 differentially expressed genes (DEGs). Among them, 744 were upregulated and 1320 were downregulated. Furthermore, MAPK, NF-kappa B, and TNF pathways were enriched based on the DEGs, and the consensus DEG was identified as TNF using a Venn diagram of those pathways. DHA promoted phosphorylation of JNK, inhibited nuclear p65, and then significantly induced TNF-α synthesis. Conclusion. DHA inhibited cell proliferation and induced apoptosis in human hepatocellular carcinoma cells by upregulating TNF expression via JNK/NF-κB pathways.http://dx.doi.org/10.1155/2019/9581327
collection DOAJ
language English
format Article
sources DOAJ
author Long Wu
Yanlei Cheng
Junjian Deng
Weiping Tao
Junjie Ye
spellingShingle Long Wu
Yanlei Cheng
Junjian Deng
Weiping Tao
Junjie Ye
Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
Evidence-Based Complementary and Alternative Medicine
author_facet Long Wu
Yanlei Cheng
Junjian Deng
Weiping Tao
Junjie Ye
author_sort Long Wu
title Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
title_short Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
title_full Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
title_fullStr Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
title_full_unstemmed Dihydroartemisinin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cell by Upregulating Tumor Necrosis Factor via JNK/NF-κB Pathways
title_sort dihydroartemisinin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cell by upregulating tumor necrosis factor via jnk/nf-κb pathways
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2019-01-01
description Background. Dihydroartemisinin (DHA) is a predominant compound in Artemisia annua L., and it has been shown to inhibit tumorigenesis. Methods. In this study, the antitumor potential of DHA was investigated in the MHCC97-L hepatocellular carcinoma cell line. Cells were treated at various concentrations of DHA, and then the cell cycle, viability, and DNA synthesis were measured to evaluate cell proliferation. Furthermore, the expression of genes and proteins related to proliferation and apoptosis was measured to determine the effects of DHA. Finally, the mechanism was investigated using RNA-sequencing to identify differentially expressed genes and signaling pathways, and JNK/NF-κB pathways were evaluated with Western blotting. Results. Cells were treated with a concentration range of DHA from 1 to 100 μM, and cell proliferation was suppressed in a dose-dependent manner. In addition, the genes and proteins involved in typical cellular functions of MHCC97-L cells were significantly inhibited. DHA treatment downregulated the angiogenic gene ANGPTL2 and the cell proliferation genes CCND1, E2F1, PCNA, and BCL2. DHA treatment significantly upregulated the apoptotic genes CASP3, CASP8, CASP9, and TNF. Global gene expression profiles identified 2064 differentially expressed genes (DEGs). Among them, 744 were upregulated and 1320 were downregulated. Furthermore, MAPK, NF-kappa B, and TNF pathways were enriched based on the DEGs, and the consensus DEG was identified as TNF using a Venn diagram of those pathways. DHA promoted phosphorylation of JNK, inhibited nuclear p65, and then significantly induced TNF-α synthesis. Conclusion. DHA inhibited cell proliferation and induced apoptosis in human hepatocellular carcinoma cells by upregulating TNF expression via JNK/NF-κB pathways.
url http://dx.doi.org/10.1155/2019/9581327
work_keys_str_mv AT longwu dihydroartemisinininhibitsproliferationandinducesapoptosisofhumanhepatocellularcarcinomacellbyupregulatingtumornecrosisfactorviajnknfkbpathways
AT yanleicheng dihydroartemisinininhibitsproliferationandinducesapoptosisofhumanhepatocellularcarcinomacellbyupregulatingtumornecrosisfactorviajnknfkbpathways
AT junjiandeng dihydroartemisinininhibitsproliferationandinducesapoptosisofhumanhepatocellularcarcinomacellbyupregulatingtumornecrosisfactorviajnknfkbpathways
AT weipingtao dihydroartemisinininhibitsproliferationandinducesapoptosisofhumanhepatocellularcarcinomacellbyupregulatingtumornecrosisfactorviajnknfkbpathways
AT junjieye dihydroartemisinininhibitsproliferationandinducesapoptosisofhumanhepatocellularcarcinomacellbyupregulatingtumornecrosisfactorviajnknfkbpathways
_version_ 1725276640736444416